Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Raw Materials (2016 - 2025)

Bio-Techne (TECH) has 16 years of Raw Materials data on record, last reported at $96.2 million in Q4 2025.

  • For Q4 2025, Raw Materials rose 14.58% year-over-year to $96.2 million; the TTM value through Dec 2025 reached $96.2 million, up 14.58%, while the annual FY2025 figure was $89.1 million, 12.22% up from the prior year.
  • Raw Materials reached $96.2 million in Q4 2025 per TECH's latest filing, up from $94.0 million in the prior quarter.
  • Across five years, Raw Materials topped out at $96.2 million in Q4 2025 and bottomed at $51.7 million in Q1 2021.
  • Average Raw Materials over 5 years is $78.2 million, with a median of $82.5 million recorded in 2023.
  • Peak YoY movement for Raw Materials: soared 43.91% in 2022, then dropped 7.45% in 2024.
  • A 5-year view of Raw Materials shows it stood at $61.6 million in 2021, then skyrocketed by 37.54% to $84.8 million in 2022, then dropped by 1.78% to $83.2 million in 2023, then grew by 0.86% to $84.0 million in 2024, then rose by 14.58% to $96.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Raw Materials were $96.2 million in Q4 2025, $94.0 million in Q3 2025, and $89.1 million in Q2 2025.